Peter A Thompson's Net Worth
Peter A Thompson's net worth is estimated to be at least $24,717,709.62 as of 05/21/2024. CoreStreet's estimation of Peter A Thompson's net worth is based on their sale of stock and current holding of stock.
Peter A Thompson is Director at Edgewise Therapeutics Inc. They have executed at least 10 trades of stock as per SEC Form 4 filings. Their most recent trade was for 454,545 units of EWTX stock on 01/23/2024. Their biggest sale was on 12/27/2023 when they sold 181,498 units of Alpine Immune Sciences Inc stock for $3,622,700.08. They typically trade 1 times per year.
Total value of insider buys:
- $19,087,992.54
Total value of insider sells:
- $5,629,717.08
Most recent insider trade:
- Jan. 23, 2024
Peter A Thompson's Insider Trading History
| Edgewise Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 23, 2024 | Director | 454,545 | $11.00 | Buy | $4,999,995.00 |
Sept. 16, 2022 | Director | 484,496 | $10.32 | Buy | $4,999,998.72 |
| Alpine Immune Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 27, 2023 | Director | 181,498 | $19.96 | Sell | $3,622,700.08 |
| Corvus Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 27, 2019 | Director | 32,923 | $3.34 | Buy | $109,962.82 |
June 10, 2016 | Director | 50,000 | $12.96 | Buy | $648,000.00 |
May 19, 2016 | Director | 6,800 | $11.77 | Buy | $80,036.00 |
March 29, 2016 | Director | 550,000 | $15.00 | Buy | $8,250,000.00 |
| Adaptimmune Therapeutics Plc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 4, 2018 | Director | 17,100 | $13.57 | Sell | $232,047.00 |
May 30, 2018 | Director | 121,000 | $13.52 | Sell | $1,635,920.00 |
May 14, 2018 | Director | 10,300 | $13.50 | Sell | $139,050.00 |